NIH's New Year's resolution?

It looks like the National Institutes of Health might ring in 2010 by getting serious about addressing conflicts of interest among its grantees.Image: NIH NIH director Francis Collins, in an interview with C-SPAN's "Newsmakers" program, said that the agency would issue a "Proposed Rule" in January or February that will seek to prevent pharmaceutical companies from ghostwriting studies for researchers and require drug makers and other medical companies to disclose financial relationships with NI

Written byBob Grant

| 2 min read

Save for Later

It looks like the National Institutes of Health might ring in 2010 by getting serious about addressing conflicts of interest among its grantees.

Image: NIH

NIH director Francis Collins, in an interview with C-SPAN's "Newsmakers" program, said that the agency would issue a "Proposed Rule" in January or February that will seek to prevent pharmaceutical companies from ghostwriting studies for researchers and require drug makers and other medical companies to disclose financial relationships with NIH-funded scientists and institutions via publicly accessible websites. "I was shocked by that revelation that people would allow their names to be used on articles they did not write, that were written for them, particularly by companies that have something to gain by the way the data is presented," Collins said in the interview, referring to reports of ghostwriting among NIH-funded researchers that have recently surfaced. "The integrity of biomedical research is something we must not compromise," Collins said. "We have to tighten up on that. There is a process ongoing at NIH to put out some new ideas about how our grantee institutions and investigators need to be more forthcoming about disclosure." Collins said that sometime in the next "month or two," the NIH will issue a "Notice of Proposed Rule Making" regarding the new requirements. "It will certainly be quite a change from the way that NIH has, in the past, largely left that to institutions. Now NIH is going to want to have a lot more information about what its investigators are up to as far as any potential conflicts." Collins' comments echo recent promises from the NIH to address conflicts among the researchers and institutions it funds. The NIH's deputy director Raynard Kington linkurl:said;http://www.the-scientist.com/blog/display/55264/ last December -- while he was acting director -- that the agency would act on conflicts in "roughly six months to a year." Then in May, the NIH put out a linkurl:call;http://www.the-scientist.com/blog/display/55685/ for public comment on more stringent conflict rules in draft form. You can watch the full "Newsmakers" interview linkurl:here.;http://www.c-span.org/Watch/Media/2009/12/27/NM/R/27605/NIH+Dir+on+the+Future+of+Biomed+Research.aspx Hat tip to __USA Today__'s "ScienceFair" linkurl:blog.;http://blogs.usatoday.com/sciencefair/2009/12/nih-chief-researchers-may-have-to-disclose-funding-sources.html
**__Related stories:__***linkurl:NIH finally takes on conflicts;http://www.the-scientist.com/blog/display/55685/
[11th May 2009]*linkurl:NIH may start policing conflicts;http://www.the-scientist.com/blog/display/55400/
[5th February 2009]*linkurl:NIH to act on conflicts within 1 year;http://www.the-scientist.com/blog/display/55264/
[5th December 2008]

Meet the Author

Bob Grant

From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

View Full Profile

NIH's New Year's resolution?

The Scientist ARCHIVES

Become a Member of

Meet the Author

Bob Grant

Related Research Resources

What Is the Amniotic Fluid Composed of?

Research Resources

Podcasts

Webinars

Videos

Infographics

eBooks

Advancing Drug Discovery with Complex Human In Vitro Models

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Maximizing Cancer Research Model Systems

Products

Product News

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies